AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug calms Alzheimer's agitation in Long-Term trial
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-05 for treating agitation in people with Alzheimer's disease. 456 participants who had already been in earlier studies took the drug, and some later switched to a placebo to see if agitation symptoms…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
New at-home pill aims to calm agitation from schizophrenia and bipolar disorder
Symptom relief CompletedThis study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 participants received either the drug or a placebo, and researchers measured changes in agitation levels and sa…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 18, 2026 12:04 UTC
-
New study examines Igalmi's effects after repeated use for agitation
Knowledge-focused CompletedThis study looked at how the body builds tolerance to Igalmi (a fast-acting medicine for agitation) and what happens when it's stopped. It involved 29 adults with schizophrenia or bipolar disorder who had frequent agitation. Researchers measured changes in agitation levels and wa…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE4 • Sponsor: BioXcel Therapeutics Inc • Aim: Knowledge-focused
Last updated May 26, 2026 09:28 UTC